Oct 22, covid-19 research and policy briefing

Focus on monoclonal antibodies; Another hope dashed? Tocilizumab not as promising as hoped in a new trial; Four clinical studies on the monoclonal antibody Tocilizumab. What does it all mean?.

Read the full article here

Related Articles